CIP
PMC

Convergence Investment Partners’s PharMerica Corporation PMC Stock Holding History

Convergence Investment Partners’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-70,550
Closed -$1.56M – 408
2016
Q1 		$1.56M Buy
+70,550
New +$1.88M 0.19% 189
2015
Q3 		– Sell
-62,760
Closed -$2.09M – 446
2015
Q2 		$2.09M Buy
+62,760
New +$1.93M 0.21% 166

Other funds holding PMC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Convergence Investment Partners's PMC Position: Q2 2016 in Review

Convergence Investment Partners sold out of PharMerica Corporation (PMC) in Q2 2016, closing a stake of 70,550 shares — an estimated $1.56M sold.

Convergence Investment Partners first reported a position in PMC in Q2 2015 and held it in 2 quarters. The position peaked at $2.09M in Q2 2015. 174 funds tracked by Wall St. Rank hold PMC as of Q2 2016.

  • Convergence Investment Partners reported no remaining PharMerica Corporation position as of Q2 2016 after selling out during the quarter.
  • Convergence Investment Partners sold 70,550 PharMerica Corporation shares in Q2 2016, an estimated $1.56M.
  • Convergence Investment Partners first reported a position in PharMerica Corporation in Q2 2015 and held it in 2 quarters.
  • Convergence Investment Partners's PharMerica Corporation position peaked at $2.09M in Q2 2015.
  • 174 funds tracked by Wall St. Rank held PharMerica Corporation as of Q2 2016.

Based on Convergence Investment Partners's 13F filing for Q2 2016, filed 10 Aug 2016.